02.06.2013 Views

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

2 ABARELIX<br />

ABARELIX<br />

Trade name: Plenaxis (Praecis)<br />

Indications: Prostate cancer (advanced)<br />

Category: Gonadotropin-releasing hormone antagonist<br />

Half-life: 13.2 days<br />

Clinically important, potentially hazardous interactions<br />

with: amiodarone, procainamide, quinidine, sotalol<br />

Reactions<br />

Skin<br />

Allergic reactions (sic)<br />

(2006): Beer TM+, Anticancer <strong>Drug</strong>s 17(9), 1075<br />

Peripheral edema (15%)<br />

Other<br />

Gynecomastia (30%)<br />

Hot flashes (79%)<br />

Pain (31%)<br />

Upper respiratory infection (12%)<br />

ABATACEPT<br />

Trade name: Orencia (Bristol-Myers Squibb)<br />

Indications: Rheumatoid arthritis<br />

Category: T-cell co-stimulation modulator<br />

Half-life: 12–23 days<br />

Clinically important, potentially hazardous interactions<br />

with: TNF antagonists<br />

Reactions<br />

Skin<br />

Pruritus (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!